CAC
Cowen and Company Portfolio holdings
AUM
$2.9B
This Quarter Return
-1.56%
1 Year Return
+104.28%
3 Year Return
+119.87%
5 Year Return
+632.2%
10 Year Return
–
AUM
$1.42B
AUM Growth
+$1.42B
(+18%)
Cap. Flow
+$343M
Cap. Flow
% of AUM
24.12%
Top 10 Holdings %
Top 10 Hldgs %
41.7%
Holding
760
New
160
Increased
218
Reduced
130
Closed
152
Top Buys
| 1 |
NVIDIA
NVDA
|
$164M |
| 2 |
Energy Select Sector SPDR Fund
XLE
|
$50.2M |
| 3 |
CVII
Churchill Capital Corp VII Class A Common Stock
CVII
|
$29.3M |
| 4 |
AdvisorShares Pure US Cannabis ETF
MSOS
|
$28.4M |
| 5 |
SiriusXM
SIRI
|
$19.8M |
Top Sells
Sector Composition
| 1 | Financials | 30.13% |
| 2 | Healthcare | 22.05% |
| 3 | Technology | 21.66% |
| 4 | Communication Services | 4.13% |
| 5 | Industrials | 4.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
NVIDIA
NVDA
$4.24T
| $248M | 17.37% | 570,721 +377,971 | +196% | +$164M |
|
2
Establishment Labs
ESTA
$1.2B
| $56M | 3.92% | 1,141,172 +175,000 | +18% | +$8.59M |
|
|
3
Energy Select Sector SPDR Fund
XLE
$27.6B
| $50.2M | 3.52% | +555,802 | New | +$50.2M |
|
|
4
AdvisorShares Pure US Cannabis ETF
MSOS
$986M
| $48.7M | 3.41% | 6,139,280 +3,573,000 | +139% | +$28.4M |
|
|
AAC
5
DELISTED
Ares Acquisition Corporation
AAC
| $36.4M | 2.55% | 3,385,401 +553,775 | +20% | +$5.96M |
|
6
Avidity Biosciences
RNA
$5.99B
| $35.9M | 2.51% | 5,629,103 | – | – |
|
7
Tarsus Pharmaceuticals
TARS
$2.47B
| $31.9M | 2.23% | 1,796,773 -202,610 | -10% | -$3.6M |
|
|
CVII
8
DELISTED
Churchill Capital Corp VII Class A Common Stock
CVII
| $29.3M | 2.05% | +2,800,465 | New | +$29.3M |
|
|
9
SiriusXM
SIRI
$7.96B
| $28.8M | 2.02% | 6,376,000 +4,376,000 | +219% | +$19.8M |
|
10
Mercer International
MERC
$223M
| $28.3M | 1.98% | 3,300,000 +1,900,000 | +136% | +$16.3M |
|
11
Protagonist Therapeutics
PTGX
$3.67B
| $27.6M | 1.93% | 1,657,551 | – | – |
|
|
AVDL
12
Avadel Pharmaceuticals
AVDL
$1.43B
| $24.1M | 1.69% | 2,338,302 -325,774 | -12% | -$3.36M |
|
13
Immunocore
IMCR
$1.62B
| $23.9M | 1.67% | 460,036 | – | – |
|
14
Meta Platforms (Facebook)
META
$1.86T
| $22.7M | 1.58% | 75,453 +32,911 | +77% | +$9.88M |
|
15
Rocket Pharmaceuticals
RCKT
$354M
| $22.5M | 1.58% | 1,100,000 | – | – |
|
|
SLAM
16
DELISTED
Slam Corp. Class A Ordinary Share
SLAM
| $20.1M | 1.4% | 1,860,843 +909,440 | +96% | +$9.8M |
|
17
Fulcrum Therapeutics
FULC
$351M
| $19.1M | 1.34% | 4,308,359 +1,191,363 | +38% | +$5.29M |
|
|
RRAC
18
DELISTED
Rigel Resource Acquisition Corp.
RRAC
| $18.9M | 1.32% | 1,731,483 +184,349 | +12% | +$2.01M |
|
19
Energy Transfer Partners
ET
$60.8B
| $18.3M | 1.28% | 1,305,000 -130,000 | -9% | -$1.82M |
|
20
PTC Therapeutics
PTCT
$3.92B
| $17.9M | 1.25% | 799,511 | – | – |
|
|
HCVIU
21
DELISTED
Hennessy Capital Investment Corp. VI Unit
HCVIU
| $17.4M | 1.22% | 1,501,275 +1,275 | +0.1% | +$14.8K |
|
22
Nabors Energy Transition Corp II
NETD
| $17.1M | 1.19% | +1,677,458 | New | +$17.1M |
|
|
PEGR
23
DELISTED
Project Energy Reimagined Acquisition Corp. Class A Ordinary Share
PEGR
| $17M | 1.19% | 1,624,118 -185,496 | -10% | -$1.94M |
|
|
TRTL
24
DELISTED
TortoiseEcofin Acquisition Corp. III
TRTL
| $15.5M | 1.08% | 1,474,505 +841,293 | +133% | +$8.82M |
|
25
Stoke Therapeutics
STOK
$1.08B
| $14.7M | 1.03% | 3,721,659 | – | – |
|